Association of HIV Status With Outcomes of Anal Squamous Cell Carcinoma in the Era of Highly Active Antiretroviral Therapy
暂无分享,去创建一个
[1] T. Kinsella,et al. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients. , 2009, International journal of radiation oncology, biology, physics.
[2] B. Seifert,et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] H. El‐Serag,et al. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] B. Sarani,et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients , 2001, Diseases of the colon and rectum.
[5] C. Simmang,et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma , 2001, Diseases of the colon and rectum.
[6] C. Rödel,et al. Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy? , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.